Jay Pepose - 08 Apr 2022 Form 4 Insider Report for Ocuphire Pharma, Inc. (IRD)

Role
Director
Signature
/s/ Emily J. Johns, by Power of Attorney
Issuer symbol
IRD
Transactions as of
08 Apr 2022
Net transactions value
$0
Form type
4
Filing time
13 Apr 2022, 13:56:32 UTC
Previous filing
14 Dec 2021
Next filing
15 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCUP Stock Option (right to buy) Award $0 +50,000 $0.000000 50,000 08 Apr 2022 Common Stock 50,000 $2.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest with respect to 12,500 shares on March 31, 2023, and then with respect to 1,041 shares on the last day of each month from April 2023 through February 2026 and with respect to 1,065 shares at the end of March 2026, subject to the Reporting Person's continuing service through each applicable vesting date.